1Hanifin JM, Ling MR, Langley R, et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy[J]. J Am Acad Dermatol, 2001, 44(1 Suppl): S28-38.
2Leung DY, Boguniewicz M, Howell MD, et al. New insights into atopic dermatitis[J]. J Clin Invest, 2004, 113(5): 651-657.
3Soter NA, Fleischer AB Jr, Webster GF, et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part Ⅱ, safety[J]. J Am Acad Dermatol, 2001, 44(1 Suppl): S39-46.
4Kang S, Lucky AW, Pariser D, et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children[J]. J Am Acad Dermatol, 2001, 44(1 Suppl): S58-64.
5Pallet A, Eichenfield LF, Leung DY, et al. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients[J]. J Am Acad Dermatol, 2001, 44(1 Suppl):Sd-7-57.
6Soter NA, Fleischer AB JR, Webster GF, et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II,safety[J]. J Am Acad Dermatol, 2001, 44(1 Suppl): S39-46.
7Hanifin JM, Ling MR, Langley R, et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy[J]. J Am Acad Dermatol, 2001, 44(1 Suppl): S28-38.
8Drake L, Prendergast M, Maher R, et ol. The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis[J]. J Am Acad Dermatol, 2001, 44(1 Suppl): S65-72.
9Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use [J]. Clin Exp Dermatol, 1994, 19(3): 210-216.
10Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use[J]. Br J Dermatol, 1995, 132(6): 942-949.
